EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells

BACKGROUND: EOC is one of the most lethal gynecological malignancy worldwide. Although the majority of EOC patients achieve clinical remission after induction therapy, over 80% relapse and succumb to the chemoresistant disease. Previous investigations have demonstrated the association of EGFR with r...

Descripción completa

Detalles Bibliográficos
Autores principales: Poursheikhani, Arash, Yousefi, Hassan, Tavakoli-bazzaz, Javad, Ghaffari, Seyed H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pasteur Institute of Iran 2020
Materias:
Full Length
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601546/
https://www.ncbi.nlm.nih.gov/pubmed/32660222
http://dx.doi.org/10.29252/ibj.24.6.365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601546/
https://www.ncbi.nlm.nih.gov/pubmed/32660222
http://dx.doi.org/10.29252/ibj.24.6.365

Ejemplares similares